TODAY'S HEADLINES

FDA approves first monthly PCSK9 inhibitor injection

FDA approved evolocumab (Repatha) Pushtronex system, the first monthly single-dose injection of a PCSK9 inhibitor. Read more

Cheaper hep C drug enters lucrative market

A new combination hep C drug approved enters a competitive, lucrative market headed up by Sovaldi and Harvoni, as well as Viekira Pak. Read more

CONTINUING PHARMACY EDUCATION

Expanding vaccination rates through pharmacist-initiated patient identification and assessment

This month's CE activity, "Expanding vaccination rates through pharmacist-initiated patient identification and assessment," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians about current vaccine recommendations so that they can identify adolescent and adult patients who may need vaccinations. Readers will also gain knowledge about where to obtain information about current vaccine recommendations.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Opioid patients lack access to treatment

A new study found that there's significant underutilization of treatment methods among patients with opioid use disorder. Read more

July 22, 2016

Related Articles

Battle of the cholesterol drugs expected

Brand and specialty drug spending spikes